Prescribing in older people

Australian Family Physician

Volumn 33, Issue 10, 2004, Pages 777-781

  Le Couteur, David G ^a   Hilmer, Sarah N ^a   Glasgow, Nicholas ^b   Naganathan, Vasi ^a   Cumming, Robert G ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; AGING; CLINICAL TRIAL; COMORBIDITY; CORONARY ARTERY DISEASE; DRUG INTERACTION; DRUG THERAPY; FRAIL ELDERLY; GERIATRICS; HUMAN; METABOLISM; MIDDLE AGED; MORTALITY; PHARMACOKINETICS; POLYPHARMACY; PRESCRIPTION; REVIEW; STATISTICS;

AGED; AGING; CLINICAL TRIALS; COMORBIDITY; CORONARY DISEASE; DRUG INTERACTIONS; DRUG THERAPY; FRAIL ELDERLY; GERIATRICS; HUMANS; MIDDLE AGED; PHARMACOKINETICS; POLYPHARMACY; PRESCRIPTIONS, DRUG;

EID: 16544394114     PISSN: 03008495     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. McLean AJ, Le Couteur DG. Aging biology and geriatric clinical pharmacology. Pharmacol Rev 2004;56:163-184.
2. Nair BR. Evidence based medicine for older people: available, accessible, acceptable, adaptable? Aust J Ageing 2002;21:58-60.
3. Flather MD, Yusuf S, Kober L, et al. Long term ACE inhibitor therapy in patients with heart failure or left ventricular dysfunction: a systematic overview of data from individual patients. ACE Inhibitor Myocardial Infarction Collaborative Group. Lancet 2000;355:1575-1581.
4. McClung MR, Geusens P, Miller PD, et al. Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group. N Engl J Med 2001;344:333-340.
5. Woodward MC. Deprescribing: achieving better health outcomes for older people through reducing medications. J Pharm Pract Res 2003;33:323-328.
6. Leipzig RM, Cumming RG, Tinetti ME. Drugs and falls in older people: a systematic review and meta-analysis: I. Psychotropic drugs. J Am Geriatr Soc 1999;47:30-39.
7. Desbiens NA. Deciding on anticoagulating the oldest old with atrial fibrillation: insights from cost effectiveness analysis. J Am Geriatr Soc 2002;50:863-869.
8. Le Couteur DG, Johnson AG. Drugs and the elderly: prescription idiosyncrasies. Modern Medicine 1997;40:30-37.
9. Le Couteur DG, Fraser R, Hilmer S, Rivory LP, McLean AJ. The hepatic sinusoid in aging and cirrhosis: effects on hepatic substrate disposition and drug clearance. Clin Pharmacokinet 2004; in press.
10. Le Couteur DG, McLean AJ. The aging liver: drug clearance and an oxygen diffusion barrier hypothesis. Clin Pharmacokinet 1998;34:359-373.
11. Atkin PA, Shenfield GM. Medication related adverse reactions and the elderly: a literature review. Adverse Drug React Toxicol Rev 1995;14:175-191.
12. Cumming RG, Le Couteur DG. Benzodiazepines and hip fractures in older people: an evaluation of the relationship. CNS Drugs 2003;17:825-837.
13. Moore AR, O'Keeffe ST. Drug induced cognitive impairment in the elderly. Drugs Aging 1999;15:15-28.
14. Rochon PA, Gurwitz JH. Optimising drug treatment for elderly people: the prescribing cascade. Br Med J 1997;315:1096-1099.
15. Campbell AJ, Robertson MC, Gardner MM, Norton RN, Buchner DM. Psychotropic medication withdrawal and a home based exercise program to prevent falls: a randomised, controlled trial. J Am Geriatr Soc 1999;47:850-853.
16. Froom J, Trilling J. Reducing antihypertensive medication use in nursing home patients. Arch Fam Med 2000;9:378-383.
17. Nelson MR, Reid CM, Krum H, Muir T, Ryan P, McNeil JJ. Predictors of normotension on withdrawal of antihypertensive drugs in elderly patients: prospective study in second Australian national blood pressure study cohort. BMJ 2002;325:815.
18. Graves T, Hanlon JT, Schmader KE, et al. Adverse events after discontinuing medications in elderly outpatients. Arch Intern Med 1997;157:2205-2210.
19. Boockvar K, Fishman E, Kyricou CK, Monias A, Gavi S, Cortes T. Adverse events due to discontinuations in drug use and dose changes in patients transferred between acute and long term care facilities. Arch Intern Med 2004;164:545-550.